Paper32023866
TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy.
Wang Y and 7 others. Int J Mol Sci, 2020. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy. Papers, record 32023866. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32023866
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchioles | Major topic |
| Radiotherapy | Major topic |
| Titanium | Major topic |
| Cell Line | |
| Cell Proliferation | |
| Cell Survival | |
| Humans | |
| Metal Nanoparticles | |
| Oxidative Stress | |
| Reactive Oxygen Species |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23647757 | The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept. | Radiother Oncol | 2013 | https://conductscience.org/library/papers/23647757 | PubMed |
| 2 | 20055707 | Mechanisms of cell protection by heme oxygenase-1. | Annu Rev Pharmacol Toxicol | 2010 | https://conductscience.org/library/papers/20055707 | PubMed |
| 3 | 20729176 | Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. | Environ Health Perspect | 2010 | https://conductscience.org/library/papers/20729176 | PubMed |
| 4 | 21744743 | Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. | Eur Rev Med Pharmacol Sci | 2011 | https://conductscience.org/library/papers/21744743 | PubMed |
| 5 | 22767269 | In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles. | Nanoscale | 2012 | https://conductscience.org/library/papers/22767269 | PubMed |
| 6 | 30920558 | Strategies to improve the photocatalytic activity of TiO2: 3D nanostructuring and heterostructuring with graphitic carbon nanomaterials. | Nanoscale | 2019 | https://conductscience.org/library/papers/30920558 | PubMed |
| 7 | 21788197 | Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. | Environ Health Perspect | 2011 | https://conductscience.org/library/papers/21788197 | PubMed |
| 8 | 22115978 | In vitro phototoxicity and hazard identification of nano-scale titanium dioxide. | Toxicol Appl Pharmacol | 2012 | https://conductscience.org/library/papers/22115978 | PubMed |
| 9 | 21358741 | Cell death assays for drug discovery. | Nat Rev Drug Discov | 2011 | https://conductscience.org/library/papers/21358741 | PubMed |
| 10 | 24978464 | Targeted radiotherapy with gold nanoparticles: current status and future perspectives. | Nanomedicine (Lond) | 2014 | https://conductscience.org/library/papers/24978464 | PubMed |
| 11 | 24576993 | Study of gamma irradiation effect on commercial TiO2 photocatalyst. | Appl Radiat Isot | 2014 | https://conductscience.org/library/papers/24576993 | PubMed |
| 12 | 16598890 | Carcinogenicity of carbon black, titanium dioxide, and talc. | Lancet Oncol | 2006 | https://conductscience.org/library/papers/16598890 | PubMed |
| 13 | 24392307 | Third generation gold nanoplatform optimized for radiation therapy. | Transl Cancer Res | 2013 | https://conductscience.org/library/papers/24392307 | PubMed |
| 14 | 24673907 | Genotoxicity of titanium dioxide nanoparticles. | J Food Drug Anal | 2014 | https://conductscience.org/library/papers/24673907 | PubMed |
| 15 | 25640001 | Review of titanium dioxide nanoparticle phototoxicity: Developing a phototoxicity ratio to correct the endpoint values of toxicity tests. | Environ Toxicol Chem | 2015 | https://conductscience.org/library/papers/25640001 | PubMed |
| 16 | 17886069 | An approach to risk assessment for TiO2. | Inhal Toxicol | 2007 | https://conductscience.org/library/papers/17886069 | PubMed |
| 17 | 17687716 | Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. | Inhal Toxicol | 2007 | https://conductscience.org/library/papers/17687716 | PubMed |
| 18 | 9380736 | Reduced stress defense in heme oxygenase 1-deficient cells. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9380736 | PubMed |
| 19 | 30523526 | Synthesis and applications of nano-TiO2: a review. | Environ Sci Pollut Res Int | 2019 | https://conductscience.org/library/papers/30523526 | PubMed |
| 20 | 21769246 | An EM Algorithm for Fitting a 4-Parameter Logistic Model to Binary Dose-Response Data. | J Agric Biol Environ Stat | 2011 | https://conductscience.org/library/papers/21769246 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36296859 | Medical and Dental Applications of Titania Nanoparticles: An Overview. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/36296859 | PubMed |
| 35565075 | Titanium Dioxide: Structure, Impact, and Toxicity. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35565075 | PubMed |
| 32150868 | Counteracting Radio-Resistance Using the Optimization of Radiotherapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32150868 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| NQO1 | 1728 | PubTator's text mining | https://conductscience.org/library/genes/1728 | NCBI Gene |
| PRDX5 | 25824 | PubTator's text mining | https://conductscience.org/library/genes/25824 | NCBI Gene |
| TXNRD1 | 7296 | PubTator's text mining | https://conductscience.org/library/genes/7296 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32023866
GET https://conductscience.org/api/papers/v1/32023866/references?page=2